A5045661012- Health Systems, Economic Evaluations, Quality of Life
- Vaccine Coverage and Hesitancy
- Respiratory viral infections research
- Viral Infections and Immunology Research
- Pediatric health and respiratory diseases
- Influenza Virus Research Studies
- Viral gastroenteritis research and epidemiology
- Global Health Care Issues
- SARS-CoV-2 and COVID-19 Research
Putnam County HomeCare & Hospice Auxiliary
2025
In the post-pandemic era, people with underlying medical conditions continue to be at increased risk for severe COVID-19 disease, yet vaccination uptake remains low. This study estimated clinical and economic impact of updated 2023/24 Moderna among high-risk adults versus no Pfizer/BioNTech vaccination. A static Markov model was adapted adults, including immunocompromised (IC), chronic lung disease (CLD), kidney (CKD), cardiovascular (CVD), diabetes mellitus (DM) populations in United States...
Following the development of a value vaccination (VoV) framework for health technology assessment/cost-effectiveness analysis (HTA/CEA), and identification three benefits near-term inclusion in HTA/CEA, this final paper provides decision makers with methods examples to consider systems strengthening (HSS), equity, macroeconomic gains. Expert working groups, targeted literature reviews, case studies were used. Opportunity cost applied HSS rotavirus vaccination. Vaccination, included, reduced...
Baloxavir marboxil (baloxavir) is a single-dose antiviral which was previously found to be cost-effective alternative laninamivir in otherwise healthy adults Japan. This study aimed at investigating the cost-effectiveness of baloxavir versus patients with influenza high risk for complications.A decision tree utilized estimate costs and health gains associated use antivirals. A lifetime horizon applied capture long-term impact complications, other events outcomes were accounted one season....
Abstract Introduction In the post-pandemic era, people with underlying medical conditions continue to be at increased risk for severe COVID-19 disease, yet vaccination uptake remains low. This study estimated clinical and economic impact of updated 2023/24 Moderna among high-risk adults versus no Pfizer/BioNTech vaccination. Methods A static Markov model was adapted adults, including immunocompromised (IC), chronic lung disease (CLD), kidney (CKD), cardiovascular (CVD), diabetes mellitus...
Abstract Background COVID-19 highlighted health inequities and the differential impact that vaccination can have on health, with respect to social advantage. While many national immunisation programmes (NIP) consider equity as a key recommendation criterion, most lack robust frameworks methods quantify of healthcare interventions equity. Equity strata be defined by socioeconomic status, race/ethnicity, geographic location, etc… Methods The inclusion in guidelines for was assessed....